These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7403242)

  • 1. Availability of oxyphenbutazone from different suppository formulations.
    Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
    Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
    Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
    Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release and rectal absorption of ethosuximide from suppositories in rabbits.
    Ghazy FS; Mohamed MS; Kassem AA; Elhoseiny BM
    Pharmazie; 1988 Jul; 43(7):484-5. PubMed ID: 3222279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories.
    Dal Zorro M; Franceschinis E; Punchina A; Realdon N
    Pharmazie; 2012 Jan; 67(1):37-45. PubMed ID: 22393829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surfactant characteristics on drug availability from suppositories.
    Realdon N; Dal Zotto M; Morpurgo M; Franceschinis E
    Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
    Onyeji CO; Adebayo AS; Babalola CP
    Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of surfactant incorporation techniques on sulphamethoxazole suppository formulations.
    Abd el-Gawad AH; el-Din EZ; Abd el-Alim HA
    Pharmazie; 1988 Sep; 43(9):624-7. PubMed ID: 3244731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories.
    Itoh S; Teraoka N; Matsuda T; Okamoto K; Takagi T; Oo C; Danny Kao H
    Eur J Pharm Biopharm; 2006 Nov; 64(3):393-8. PubMed ID: 16890412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
    Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
    Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro release of chloramphenicol from different suppository bases.
    Kassem AA; Nour El-Din E; Abd El-Bary A; Fadel HM
    Pharmazie; 1975 Jul; 30(7):472-5. PubMed ID: 1178767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dynamics of drug release from suppositories. Part 2: Phenylpyrazolone derivatives in animal experimentation (author's transl)].
    Pasich J; Galoch B; Kustra K
    Pharmazie; 1979 Jul; 34(7):413-4. PubMed ID: 504331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release and rectal absorption of aminophylline suppositories prepared in a hospital pharmacy.
    Fujii T; Kubota A; Mizushima N
    Tokai J Exp Clin Med; 1982 Sep; 7(5):539-46. PubMed ID: 7182946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
    Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
    J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with the rectal use of a chemotherapeutic agent. 1. In vitro biopharmaceutical examinations; selection of the optimal vehicle].
    Regdon G; Erös I; Gombkötö Z; Németh J; Regdon G; Vernyik A; Sallai J
    Acta Pharm Hung; 1998 Jul; 68(4):224-8. PubMed ID: 9737023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced release of diazepam from hollow-type suppositories.
    Kaewnopparat N; Kaewnopparat S; Rojanarat W; Ingkatawornwong S
    Int J Pharm Compd; 2004; 8(4):310-2. PubMed ID: 23924703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a rectal suppository containing the antiepileptic drug zonisamide.
    Nagatomi A; Mishima M; Tsuzuki O; Ohdo S; Higuchi S
    Biol Pharm Bull; 1997 Aug; 20(8):892-6. PubMed ID: 9300137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
    Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
    J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.